COVID-19 AND SYSTEMIC ARTERIAL HYPERTENSION: RISK FACTOR FOR MORBIMORTALITY. SYSTEMATIC REVIEW

Autores

DOI:

https://doi.org/10.47820/recima21.v2i10.734

Palavras-chave:

COVID-19, investigate the relationship between systemic arterial hypertension

Resumo

Objective: To investigate the relationship between systemic arterial hypertension and morbidity and mortality in individuals infected with SARS-CoV-2. Materials and Methods: This is a systematic review, carried out in the databases of MEDLINE/PubMed®, SciELO/Lilacs, Virtual Health Library (VHL), EBSCO and Google Scholar. The descriptors in the English language were used: “COVID-19”; "SARS-CoV-2"; "Systemic arterial hypertension"; “Complications”; "Risk factor". The search resulted in 1,005 articles. Among these, duplicate articles were excluded, as well as studies that showed methodological inconsistencies. At the end, 12 articles were selected. Results: Studies have shown the high prevalence of SARS-CoV-2 infection in patients with systemic arterial hypertension. Such patients showed an inflammatory response secondary to exacerbated infection, forming part of the high-risk group of the disease. Considering the complications in this specific subgroup, a change in lifestyle and strict adherence to drug therapy are necessary. Conclusions: Systemic arterial hypertension is associated with a worse prognosis and higher mortality of patients hospitalized by COVID-19.

Downloads

Não há dados estatísticos.

Biografia do Autor

Marcel Vasconcellos, Centro Universitário Serra dos Órgãos-UNIFESO

Centro Universitário Serra dos Órgãos-UNIFESO

Carla Carolina de Paula Liberato

Graduate student. School of Medicine. Centro Universitário Serra dos Órgãos. Rio de Janeiro-RJ. Brazil.

Carolina Miranda Mourão Bastos

¹Graduate student. School of Medicine. Centro Universitário Serra dos Órgãos. Rio de Janeiro-RJ. Brazil.

Leilane Maria Moreira Araujo

Graduate student. School of Medicine. Centro Universitário Serra dos Órgãos. Rio de Janeiro-RJ. Brazil.

Luiza Machado Borges

Graduate student. School of Medicine. Centro Universitário Serra dos Órgãos. Rio de Janeiro-RJ. Brazil.

Maria Clara Pedrosa Rebello

Graduate student. School of Medicine. Centro Universitário Serra dos Órgãos. Rio de Janeiro-RJ. Brazil.

Referências

Malachias MVB, Plavnik FL, Machado CA, Malta D, Scala LCN, Fuchs S. 7ª Diretriz Brasileira de Hipertensão Arterial: Capítulo 1 - Conceituação, Epidemiologia e Prevenção Primária. Arq. Bras. Cardiol. 2016;107(Suppl 3):1-6.

Barros GM, Mazullo Filho JBR, Júnior ACM. Considerações sobre a relação entre a hipertensão e o prognóstico da COVID-19. Journal of Health & Biological Sciences. 2020;8(1):1-3.

Rodrigues CMB, da Costa NB, Vieira VR, Gabriel EA, Gabriel SA. COVID-19: sistema renal e cardíaco. Ulakes Journal of Medicine, 2020;1(EE):60-6.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020;395(10223):507-13.

Pinotti F, Wikramaratna PS, Obolski U, Paton R, Damineli DSC, Alcantara LCJ, Lourenço J. Potential impact of individual exposure histories to endemic human coronaviruses on age-dependence in severity of COVID-19. medRxiv. 2020;20154369.

Oliveira GMMD, & Pinto FJ. COVID-19: A Matter Close to the Heart. International Journal of Cardiovascular Sciences. 2020;33(3):199-202.

Khera A, Baum SJ, Gluckman TJ, Gulati M, Martin SS, Michos ED, Wong ND. Continuity of care and outpatient management for patients with and at high risk for cardiovascular disease during the COVID-19 pandemic: A scientific statement from the American Society for Preventive Cardiology. American Journal of Preventive Cardiology. 2020;1:100009.

Pinto BG, Oliveira AE, Singh Y, Jimenez L, Gonçalves ANA, Ogava RL, Nakaya HI. ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. The Journal of Infectious Diseases. 2020;222(4):556–63.

Brandão SCS, Godoi ETAM, Ramos JOX, Melo LMMP de, Dompieri LT, Brindeiro Filho DF, et al. Papel do Endotélio na COVID-19 Grave. Arq. Bras. Cardiol. 2020;115(6):1184-89.

Costa IBSDS, Bittar CS, Rizk SI, Araújo Filho AED, Santos KAQ, Machado TIV, Bacal F. O Coração e a COVID-19: O que o Cardiologista Precisa Saber. Arq. Bras. Cardiol. 2020;114(5):805-16.

Rodrigues CIS. Posicionamento do Departamento de Hipertensão da Sociedade Brasileira de Nefrologia: Bloqueadores do sistema renina-angiotensina durante o curso de infecção pela Covid-19. Brazilian Journal of Nephrology. 2020;42(2):47-8.

Ferreira MJ, Irigoyen MC, Consolim-Colombo F, Saraiva JFK, Angelis KD. Vida Fisicamente Ativa como Medida de Enfrentamento ao COVID-19. Arq. Brasil. Cardiol. 2020;114(4):601-02.

Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico Especial 14: Doença pelo Coronavírus 2019, de 21 a 27/2/2021. Semana Epidemiológica 18. Brasília: DF. Ministério da Saúde, 2021.

: Doença pelo Coronavírus 2019, de 21 a 27/2/2021. Semana Epidemiológica 18. Brasília: DF. Ministério da Saúde, 2021.

Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Salomon SD. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. N Engl J Med. 2020. [Epub ahead of print].

Downloads

Publicado

28/10/2021

Como Citar

Vasconcellos, M., Paula Liberato, C. C. de ., Miranda Mourão Bastos , C. ., Moreira Araujo , L. M. . . . . . ., Machado Borges, L. . . . . . . . . . . . . . . . . . ., & Pedrosa Rebello , M. C. . . . . . . (2021). COVID-19 AND SYSTEMIC ARTERIAL HYPERTENSION: RISK FACTOR FOR MORBIMORTALITY. SYSTEMATIC REVIEW. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 2(10), e210734. https://doi.org/10.47820/recima21.v2i10.734

Artigos mais lidos pelo mesmo(s) autor(es)